BCL2L1 and cancer: Hence, small molecules that promote the pro-apoptotic alternative Bcl-xS isoform (such as PhenDC3, PhenDH8 and PhenDH9) may represent prototypes of candidate drugs to re-sensitize cancer cells to chemotherapy.